Johns Hopkins ABX Guide
Carbenicillin indanyl sodium
INDICATIONS
FDA
FDA
- No longer available in the U.S.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Upper and lower UTI caused by Enterobacter, Escherichia coli, Proteus (indole-positive infections), and P. aeruginosa.
- Prostatitis
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: October 16, 2022
Citation
Dzintars, Kathryn, and Paul G Auwaerter. "Carbenicillin Indanyl Sodium." Johns Hopkins ABX Guide, The Johns Hopkins University, 2022. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540080/all/Carbenicillin_indanyl_sodium.
Dzintars K, Auwaerter PG. Carbenicillin indanyl sodium. Johns Hopkins ABX Guide. The Johns Hopkins University; 2022. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540080/all/Carbenicillin_indanyl_sodium. Accessed December 30, 2024.
Dzintars, K., & Auwaerter, P. G. (2022). Carbenicillin indanyl sodium. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540080/all/Carbenicillin_indanyl_sodium
Dzintars K, Auwaerter PG. Carbenicillin Indanyl Sodium [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2022. [cited 2024 December 30]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540080/all/Carbenicillin_indanyl_sodium.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Carbenicillin indanyl sodium
ID - 540080
A1 - Dzintars,Kathryn,Pharm.D., BCPS
AU - Auwaerter,Paul,M.D.
Y1 - 2022/10/16/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540080/all/Carbenicillin_indanyl_sodium
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
